Skip Navigation


Human Molecular Genetics Advance Access originally published online on January 18, 2007
Human Molecular Genetics 2007 16(5):529-536; doi:10.1093/hmg/ddl485
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/5/529    most recent
ddl485v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Massey-Harroche, D.
Right arrow Articles by Le Bivic, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massey-Harroche, D.
Right arrow Articles by Le Bivic, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Evidence for a molecular link between the tuberous sclerosis complex and the Crumbs complex

Dominique Massey-Harroche1, Marie-Hélène Delgrossi1, Lydie Lane-Guermonprez1, Jean-Pierre Arsanto1, Jean-Paul Borg2,3,4, Marc Billaud5 and André Le Bivic1,*

1 IDBML, CNRS UMR6216, Case 907, Faculté des Sciences de Luminy, 13288 Marseille cedex 09, France, 2 Inserm, U599, Centre de Recherche en Cancérologie de Marseille and 3 Institut Paoli-Calmettes, Marseille F-13009, France, 4 Univ Méditerranée, Marseille F-13007, France and 5 LGMSC, CNRS UMR 5201, Domaine Rockefeller, 8 Av Rockefeller, 68373 Lyon cedex 08, France

* To whom correspondence should be addressed. Tel: +33 491269741; Fax: +33 491269748; Email: lebivic{at}ibdm.univ-mrs.fr

Received October 18, 2006; Revised December 8, 2006; Accepted December 30, 2006

In human, mutations in tuberous sclerosis complex protein 1 or 2 (TSC1/2 or hamartin/tuberin) cause tuberous sclerosis characterized by the occurrence of multiple hamartomas. On the other hand, mutations in the Crumbs homolog-1 (CRB1) gene cause retinal degeneration diseases including Leber congenital amaurosis and retinitis pigmentosa type 12. Here we report, using a two-hybrid assay, a direct molecular interaction between TSC2 C-terminal part and PDZ 2 and 3 of PATJ, a scaffold member of the Crumbs 3 (CRB 3) complex in human intestinal epithelial cells, Caco2. TSC2 interacts not only with PATJ, but also with the whole CRB 3 complex by GST-pull down assays. In addition, TSC2 co-immunoprecipitates and co-localizes partially with PATJ at the level of the tight junctions. Furthermore, depletion of PATJ from Caco2 cells induces an increase in mammalian Target Of Rapamycin Complex 1 (mTORC1) activity, which is totally inhibited by rapamycin. In contrast, in the same cells, inhibition of phosphoinositol-3 kinase (PI-3K) by wortmannin does not abolish rpS6 phosphorylation. These functional data indicate that the Crumbs complex is a potential regulator of the mTORC1 pathway, cell metabolism and survival through a direct interaction with TSC1/2.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
K. Duning, E.-M. Schurek, M. Schluter, M. Bayer, H.-C. Reinhardt, A. Schwab, L. Schaefer, T. Benzing, B. Schermer, M. A. Saleem, et al.
KIBRA Modulates Directional Migration of Podocytes
J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1891 - 1903.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.